We provide niche formulations from our US FDA and EU approved manufacturing partners, empowering pharmaceutical companies to build a strong and competitive portfolio. Through strategic and marketing collaborations, with CDMOs, we facilitate the commercialization of high-value generics. For complex products with intellectual property restrictions, we offer specialized early-entry solutions to ensure a competitive market advantage.

Our dedicated account and techno commercial managers provide end-to-end support, addressing challenges during the dossier submission phase and commercial supply. This streamlined approach enhances product registration efficiency and ensures a seamless supply chain